1. Introduction: Physics Inside the Radiation Oncology Clinic
Modern radiation oncology delivers millimeter-accurate cytotoxic energy into deep-seated malignancies while sparing adjacent organs at risk such as the brainstem, spinal cord, heart, and optic apparatus. Unlike pharmacological systemic therapies, external-beam radiotherapy and brachytherapy are governed directly by measurable electromagnetic, nuclear, and atomic transport equations. Every treatment monitor unit (MU), wedge angle, multileaf collimator (MLC) aperture, and intensity-modulated fluence map represents a numerical solution to radiation transport in heterogeneous human tissue.
For medical students, physics undergraduates, and medical physics trainees preparing for American Board of Radiology (ABR) Part 1 examinations or clinical radiation oncology rotations, mastering clinical physics requires connecting four pillars: (1) relativistic electron acceleration and bremsstrahlung beam generation inside a medical linear accelerator (LINAC); (2) energy-dependent photon interaction cross sections in tissue and shielding barriers; (3) longitudinal charged-particle equilibrium and Percent Depth Dose (PDD) dosimetry; and (4) heavy charged-particle Bethe-Bloch energy loss culminating in the proton Bragg peak.
2. The Medical Linear Accelerator (LINAC) & Bremsstrahlung Production
Clinical megavoltage radiotherapy machines operate as microwave-driven relativistic electron accelerators. An electron gun emits thermionic electrons that are injected into an evacuated standing-wave or traveling-wave accelerating waveguide powered by S-band (~2856 MHz) or C-band radiofrequency microwaves generated by a magnetron or klystron. Within approximately one meter of copper resonant cavities, electrons reach kinetic energies between 6 MeV and 18 MeV—traveling at over 99.6% of the speed of light, where relativistic mass-energy scaling governs cavity synchrony.
In photon mode, this pencil beam strikes a high-atomic-number transmission target (commonly tungsten, Z = 74, paired with copper for thermal dissipation). As incident electrons decelerate in the Coulomb fields of tungsten nuclei, they emit continuous-spectrum bremsstrahlung X-rays alongside characteristic target photons. Because radiative stopping power scales roughly proportionally with incident electron kinetic energy and target atomic number (S_rad ∝ E · Z²), tungsten yields high photon production efficiency. At megavoltage energies, relativistic kinematics collimates the bremsstrahlung photon cone strongly forward along the beam axis, necessitating a conical flattening filter in conventional 3D-CRT/IMRT modes—or flattening-filter-free (FFF) operation when ultra-high dose rates above 1400 MU/min are desired for stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT).
In electron mode, the tungsten target and flattening filter are retracted from the beam path, and a thin low-Z scattering foil spreads the needle electron beam symmetrically across clinical applicator cones (4–20 MeV) to treat superficial cutaneous or chest-wall targets.
3. Photon Interactions in Matter: Photoelectric, Compton & Pair Production
Because uncharged photons ionize tissue indirectly, therapeutic energy deposition unfolds in a two-step cascade: first, photons transfer kinetic energy to secondary electrons or positrons; second, those energetic charged particles deposit energy locally via thousands of Coulombic ionizations and excitations along their tracks. Three primary interaction mechanisms compete across clinical energies:
- Photoelectric Effect (
τ/ρ ∝ Z³ / E³): Dominant at diagnostic kilovoltage energies (20–120 kVp, KV cone-beam CT, and superficial skin therapy). An incident photon transfers its entire energyhνto an inner-shell (typically K-shell) bound electron, ejecting it with kinetic energyK_e = hν - E_b. Because of its steepZ³dependence, bone (effective atomic numberZ_eff ≈ 13.8) absorbs dramatically more kilovoltage radiation than soft tissue (Z_eff ≈ 7.4)—creating crisp skeletal contrast on diagnostic radiographs and cone-beam CT, while explaining why kilovoltage orthovoltage radiotherapy is unsuitable for tumors shielded by bone. - Compton Scattering (
σ/ρ ∝ ρ_e): Dominant across soft tissue from roughly 100 keV to 10 MeV—spanning virtually the entire therapeutic range of ⁶⁰Co (1.25 MeV) and 6–10 MV clinical LINACs. An incident photon scatters inelastically off an essentially free outer-shell electron through angleθ, losing energy according to the Compton wavelength shift equation. Crucially, the Compton mass attenuation coefficient per gram depends only on electron density (electrons per gram, nearly constant at ~3.3 × 10²³ e⁻/g across muscle, fat, lung, and bone except hydrogen-rich lipids). As a result, megavoltage beams penetrate cortical bone without severe bone-marrow overdosing or distal acoustic-like shadowing. - Pair Production (
κ/ρ ∝ Zabove1.022 MeV): Strictly forbidden below the threshold photon energy of2 m_e c² = 1.022 MeV, a high-energy photon interacts with the intense electric field near an atomic nucleus and transforms completely into an electron-positron pair. Excess energy above 1.022 MeV splits as kinetic energy between the two particles; when the positron slows to rest, it annihilates with an ambient electron into two opposing 511 keV annihilation photons (the physical signature exploited simultaneously in PET imaging and emerging biology-guided radiotherapy). Pair production rises rapidly with photon energy and atomic number, becoming clinically significant in 15–18 MV beams and high-Z lead/tungsten MLC collimators. Above ~10 MV in high-Z LINAC head components, photonuclear(γ,n)reactions can also liberate fast photoneutrons, demanding borated polyethylene vault doors.
To test shielding thickness calculations with Half-Value Layers (HVL) and Tenth-Value Layers (TVL) across these regimes, open the Photon Attenuation, HVL & TVL Calculator or run the Interactive Photon Interaction Simulator.
4. Kerma, Absorbed Dose, Skin Sparing & Percent Depth Dose (PDD)
Medical physics distinguishes carefully between KERMA (Kinetic Energy Released per unit Mass, denoted K, in Gy) and Absorbed Dose (D, energy locally absorbed per unit mass, in Gy). Immediately at the patient skin surface (depth z = 0), incoming primary megavoltage photons interact to liberate high-speed forward-directed Compton electrons, so collision kerma K_col is actually maximal at or near the surface. However, those forward-moving electrons carry most of their kinetic energy deeper into the tissue over millimeters to centimeters before depositing it.
Consequently, absorbed dose starts low at the skin (typically 15–35% of maximum dose for 6–18 MV beams), rises steeply through the buildup region, reaches 100% at the depth of maximum dose d_max (where transient charged-particle equilibrium is achieved: d_max ≈ 0.5 cm for ⁶⁰Co, 1.5 cm for 6 MV, 2.5 cm for 10 MV, and 3.2 cm for 18 MV), and thereafter decays nearly exponentially with depth as the photon fluence is attenuated and diverges inversely with squared distance. Notice how this physical buildup curve explains one of the defining clinical advantages of megavoltage LINACs over orthovoltage X-rays: reliable skin sparing that spares patients severe moist desquamation during deep pelvic, thoracic, and head-and-neck irradiation.
Depth-dose behavior is parameterized clinically via Percent Depth Dose: PDD(d, r, SSD) = 100 × D_d / D_dmax. Because PDD is normalized to a fixed source-to-surface setup, changing treatment distance requires geometric correction via the Mayneord F-factor, which you can explore quantitatively using our Inverse-Square Law & Mayneord F-Factor Calculator.
5. Electron Beams vs. Proton Therapy & the Bragg Peak
While megavoltage photons exhibit an exponential exit tail that continues irradiating healthy organs distal to the tumor, charged particles—clinical electrons and heavier protons or carbon ions—possess a finite physical range governed by the Bethe-Bloch collisional stopping power equation:
-dE/dx ∝ (z² / β²) · ρ_e · [ ln(2m_e c² β² γ² / I) - β² ]
For relativistic clinical electrons (small rest mass m_e = 0.511 MeV/c²), large-angle multiple Coulomb scattering diffuses their tracks laterally and longitudinally inside tissue, creating a gentle high-dose plateau followed by a brisk falloff over a few centimeters. Useful medical physics rules of thumb in water estimate practical electron range R_p (cm) ≈ E(MeV) / 2, depth of 50% dose R_50 ≈ E / 2.33, and therapeutic 90% isodose coverage R_90 ≈ E / 3.2.
For protons (mass M_p = 938.3 MeV/c², roughly 1836 times heavier than electrons), straight-ahead trajectories dominate. Early along the beam path, proton velocity β = v/c is high, so ionization density (∝ 1/β²) stays low—sparing proximal entrance tissues. As the proton decelerates near the end of its continuous-slowing-down-approximation (CSDA) range, β² plunges toward zero, causing stopping power to spike dramatically in a narrow distal peak called the Bragg Peak before dropping cleanly to zero exit dose millimeters beyond the target. In clinical proton radiotherapy, multiple monoenergetic Bragg peaks of graded energies and weights are superimposed to widen the peak across the full tumor thickness, creating a uniform Spread-Out Bragg Peak (SOBP)—ideal for pediatric craniospinal irradiation, base-of-skull chordomas, ocular melanomas, and thoracic re-irradiation near the heart and esophagus.
Explore both photon PDD curves and interactive SOBP modulation live in our Percent Depth Dose & Proton Bragg Peak Canvas Simulator, then pair physical dosimetry with biological dose modeling in our companion Linear-Quadratic Radiobiology & BED/EQD2 Guide.